Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).
Lonial S, Nooka AK, Thulasi P, Badros AZ, Jeng BH, Callander NS, Potter HA, Sborov D, Zaugg BE, Popat R, Degli Esposti S, Byrne J, Opalinska J, Baron J, Piontek T, Gupta I, Dana R, Farooq AV, Colby K, Jakubowiak A.
Lonial S, et al. Among authors: thulasi p.
Blood Cancer J. 2021 May 26;11(5):103. doi: 10.1038/s41408-021-00494-4.
Blood Cancer J. 2021.
PMID: 34039952
Free PMC article.
Clinical Trial.